BIOTECHNOLOGY-DRIVEN VACCINE MANUFACTURING AND QUALITY CONTROL FOR CARDIOVASCULAR PROTECTION: CHALLENGES AND PUBLIC HEALTH OPPORTUNITIES. Biosci. Insights. 2026;3(02):208-223. Accessed November 13, 2026. https://www.biosciinsights.com/index.php/BI/article/view/69